Intended for healthcare professionals

Editorials

Lavage treatments for calcific rotator cuff tendinopathy

BMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2248 (Published 11 October 2023) Cite this as: BMJ 2023;383:p2248

Linked Research

Ultrasound guided lavage with corticosteroid injection versus sham lavage with and without corticosteroid injection for calcific tendinopathy of shoulder

  1. David M Robinson, sports medicine physiatrist1,
  2. Kelly C McInnis, sports medicine physiatrist1,
  3. Hye Chang Rhim, resident2,
  4. Nicholas Tsitsilianos, sports medicine fellow2
  1. 1Department of Physical Medicine and Rehabilitation and Division of Sports Medicine, Mass General Brigham and Spaulding Rehabilitation Hospital/Harvard Medical School, Boston, MA, USA
  2. 2Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital/Harvard Medical School, Charlestown, MA, USA
  1. Correspondence to: D M Robinson drobinson22{at}mgb.org

New trial challenges current treatment paradigms

Calcific tendinopathy is a painful condition characterized by calcium hydroxyapatite deposition within a tendon, most commonly the shoulder. Many factors are classically thought to be important when considering a treatment regimen, such as duration and severity of symptoms, characteristics of the calcification, and the patient’s goals.

Subacromial bursal corticosteroid injection with and without ultrasound guided lavage and shockwave therapy are widely studied interventions, and meta-analyses suggest that ultrasound guided lavage with steroid injection is associated with the greatest clinical benefits.12 However, interventional studies to date have usually lacked a sham treatment control group. In the linked BMJ paper (doi:10.1136/bmj-2023-076447), Moosmayer and colleagues report their multi-arm, double blinded, sham controlled, randomized controlled trial, conducted in an effort to fill this important evidence gap and challenge the claims of previous interventional trials.3

Moosmayer and colleagues should be commended on a well conducted randomized controlled trial, representing one of the largest sample sizes to date (220 patients). Patients were randomized to receive ultrasound guided lavage plus subacromial injection with 20 mg triamcinolone and 9 mL of 1% lidocaine (lavage+steroid), sham lavage plus the same subacromial injection (sham lavage+steroid), or sham lavage plus subacromial injection of 10 mL of 1% lidocaine only (sham). Lavage was done using a single needle technique. Participants in …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription